Advent Life Sciences, Medicxi Ventures (Index Ventures’ life sciences vehicle) and Osage University Partners have led a £11m series-A for London-based biotechnology business Capella Bioscience.
Strategy will target later-stage life sciences businesses, as well as undervalued listed companies
Fund has a special focus on the e-commerce, software, cybersecurity, fintech and blockchain sectors
GP is looking to invest in 35 tech startups in Europe and the US that are focused on the climate
Partners Hubert Deitmers and Martijn Hamann will now be the sole owners of the firm